A Case of Advanced Renal Cell Carcinoma With Concomitant Development of Multiple Endocrine Neoplasia Type 1 That Affected Treatment Progress With Immunotherapy

A Case of Advanced Renal Cell Carcinoma With Concomitant Development of Multiple Endocrine Neoplasia Type 1 That Affected Treatment Progress With Immunotherapy

ABSTRACT Introduction Hypercalcemia is a poor prognostic factor in advanced cancer. Case Presentation A patient with advanced clear cell renal carcinoma with hypercalcemia was treated with nivolumab+ipilimumab combination therapy. Treatment was discontinued after 4 months due to renal dysfunction. A...

Full description

Saved in:
Bibliographic Details
Main Authors: Masataka Abe, Yoshiyuki Miyaji, Seitetsu Sugiyama, Kiwami Tsurui, Hirofumi Morinaka, Mikako Kaifu, Hiroyuki Kadoya, Wataru Saito, Koji Yoshida, Kazumasa Komura
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:IJU Case Reports
Subjects:
durable response
hypercalcemia
metastatic renal cell carcinoma
multiple endocrine neoplasia type 1
nivolumab plus ipilimumab
Online Access:https://doi.org/10.1002/iju5.70034
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items